Prelude Therapeutics Inc - PRLD - stock price prediction, stock price target, analyst ratings from 5 analysts

Prelude Therapeutics Inc has a share price target of US$ 9, revenue growth forecast of 258.8%, and profit growth estimate of 69.2% for FY26, based on top 5 analyst calls.